2-(tert-Butyl) 3-ethyl 2,8-diazaspiro[4.5]decane-2,3-dicarboxylate

Catalog No. :
ACTBJE569
CAS No. :
1822453-48-4
Molecular Formula :
C16H28N2O4
Molecular Weight :
312.41

IUPAC Name:2-(tert-butyl) 3-ethyl 2,8-diazaspiro[4.5]decane-2,3-dicarboxylate

2-(tert-Butyl) 3-ethyl 2,8-diazaspiro[4.5]decane-2,3-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$505.00Login to see priceIn stockInquiry
250mg97%$769.00Login to see priceIn stockInquiry
1g97%$1900.00Login to see priceIn stockInquiry
5g97%$5797.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(tert-Butyl) 3-ethyl 2,8-diazaspiro[4.5]decane-2,3-dicarboxylate
IUPAC Name2-(tert-butyl) 3-ethyl 2,8-diazaspiro[4.5]decane-2,3-dicarboxylate
MDL No.MFCD22397664
Molecular FormulaC16H28N2O4
Molecular Weight312.41
SMILESO=C(N1CC2(CCNCC2)CC1C(OCC)=O)OC(C)(C)C
InChI KeyUIMVZWPYWOZZGY-UHFFFAOYSA-N
Synonym1822453-48-4 | 2-tert-Butyl 3-ethyl 2,8-diazaspiro[4.5]decane-2,3-dicarboxylate | 2-(tert-Butyl) 3-ethyl 2,8-diazaspiro[4.5]decane-2,3-dicarboxylate | 2-O-tert-butyl 3-O-ethyl 2,8-diazaspiro[4.5]decane-2,3-dicarboxylate | SCHEMBL16555309 | MFCD22397664 |
CAS No.1822453-48-4
PubChem CID117942129

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTBJE569 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTBJE569 route product structure diagram
    ACTBJE5691822453-48-4 In Stock
Inquiry

2. ACTBJE569 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTBJE569 route product structure diagram
    ACTBJE5691822453-48-4 In Stock
Inquiry

Comments (0)